Cargando…

Beyond Multiparametric MRI and towards Radiomics to Detect Prostate Cancer: A Machine Learning Model to Predict Clinically Significant Lesions

SIMPLE SUMMARY: Early diagnosing clinically significant prostate cancer (csPCa) through Magnetic Resonance Imaging (MRI) is very challenging and, nowadays, csPCa confirmation comes exclusively from prostate biopsy. However, biopsy is an invasive procedure and it also frequently causes csPCa misclass...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaudiano, Caterina, Mottola, Margherita, Bianchi, Lorenzo, Corcioni, Beniamino, Cattabriga, Arrigo, Cocozza, Maria Adriana, Palmeri, Antonino, Coppola, Francesca, Giunchi, Francesca, Schiavina, Riccardo, Fiorentino, Michelangelo, Brunocilla, Eugenio, Golfieri, Rita, Bevilacqua, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776977/
https://www.ncbi.nlm.nih.gov/pubmed/36551642
http://dx.doi.org/10.3390/cancers14246156
_version_ 1784855991367499776
author Gaudiano, Caterina
Mottola, Margherita
Bianchi, Lorenzo
Corcioni, Beniamino
Cattabriga, Arrigo
Cocozza, Maria Adriana
Palmeri, Antonino
Coppola, Francesca
Giunchi, Francesca
Schiavina, Riccardo
Fiorentino, Michelangelo
Brunocilla, Eugenio
Golfieri, Rita
Bevilacqua, Alessandro
author_facet Gaudiano, Caterina
Mottola, Margherita
Bianchi, Lorenzo
Corcioni, Beniamino
Cattabriga, Arrigo
Cocozza, Maria Adriana
Palmeri, Antonino
Coppola, Francesca
Giunchi, Francesca
Schiavina, Riccardo
Fiorentino, Michelangelo
Brunocilla, Eugenio
Golfieri, Rita
Bevilacqua, Alessandro
author_sort Gaudiano, Caterina
collection PubMed
description SIMPLE SUMMARY: Early diagnosing clinically significant prostate cancer (csPCa) through Magnetic Resonance Imaging (MRI) is very challenging and, nowadays, csPCa confirmation comes exclusively from prostate biopsy. However, biopsy is an invasive procedure and it also frequently causes csPCa misclassification. This study develops a non-invasive machine learning method for early predicting csPCa based on radiomic MRI image analysis. The main novelty of this study is investigating the radiomic differences between progressive risk groups of PCa, attributed according to the biopsy outcome and Gleason Grade group stratification. Besides predicting csPCa with very good performance (sensitivity = specificity = 84% in the test phase), this study highlights patients with GG = 2 as non-csPCa (being statistically equivalent to GG = 1), so that GG = 2 can be counselled for follow up, whilst GG ≥ 3 admitted to radical treatments. Not least, this study provides a plausible clinical interpretation of radiomic features, by discussing their values with respect to the histological meaning. ABSTRACT: The risk of misclassifying clinically significant prostate cancer (csPCa) by multiparametric magnetic resonance imaging is consistent, also using the updated PIRADS score and although different definitions of csPCa, patients with Gleason Grade group (GG) ≥ 3 have a significantly worse prognosis. This study aims to develop a machine learning model predicting csPCa (i.e., any GG ≥ 3 lesion at target biopsy) by mpMRI radiomic features and analyzing similarities between GG groups. One hundred and two patients with 117 PIRADS ≥ 3 lesions at mpMRI underwent target+systematic biopsy, providing histologic diagnosis of PCa, 61 GG < 3 and 56 GG ≥ 3. Features were generated locally from an apparent diffusion coefficient and selected, using the LASSO method and Wilcoxon rank-sum test (p < 0.001), to achieve only four features. After data augmentation, the features were exploited to train a support vector machine classifier, subsequently validated on a test set. To assess the results, Kruskal–Wallis and Wilcoxon rank-sum tests (p < 0.001) and receiver operating characteristic (ROC)-related metrics were used. GG1 and GG2 were equivalent (p = 0.26), whilst clear separations between either GG[1,2] and GG ≥ 3 exist (p < 10 [Formula: see text]). On the test set, the area under the curve = 0.88 (95% CI, 0.68–0.94), with positive and negative predictive values being 84%. The features retain a histological interpretation. Our model hints at GG2 being much more similar to GG1 than GG ≥ 3.
format Online
Article
Text
id pubmed-9776977
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97769772022-12-23 Beyond Multiparametric MRI and towards Radiomics to Detect Prostate Cancer: A Machine Learning Model to Predict Clinically Significant Lesions Gaudiano, Caterina Mottola, Margherita Bianchi, Lorenzo Corcioni, Beniamino Cattabriga, Arrigo Cocozza, Maria Adriana Palmeri, Antonino Coppola, Francesca Giunchi, Francesca Schiavina, Riccardo Fiorentino, Michelangelo Brunocilla, Eugenio Golfieri, Rita Bevilacqua, Alessandro Cancers (Basel) Article SIMPLE SUMMARY: Early diagnosing clinically significant prostate cancer (csPCa) through Magnetic Resonance Imaging (MRI) is very challenging and, nowadays, csPCa confirmation comes exclusively from prostate biopsy. However, biopsy is an invasive procedure and it also frequently causes csPCa misclassification. This study develops a non-invasive machine learning method for early predicting csPCa based on radiomic MRI image analysis. The main novelty of this study is investigating the radiomic differences between progressive risk groups of PCa, attributed according to the biopsy outcome and Gleason Grade group stratification. Besides predicting csPCa with very good performance (sensitivity = specificity = 84% in the test phase), this study highlights patients with GG = 2 as non-csPCa (being statistically equivalent to GG = 1), so that GG = 2 can be counselled for follow up, whilst GG ≥ 3 admitted to radical treatments. Not least, this study provides a plausible clinical interpretation of radiomic features, by discussing their values with respect to the histological meaning. ABSTRACT: The risk of misclassifying clinically significant prostate cancer (csPCa) by multiparametric magnetic resonance imaging is consistent, also using the updated PIRADS score and although different definitions of csPCa, patients with Gleason Grade group (GG) ≥ 3 have a significantly worse prognosis. This study aims to develop a machine learning model predicting csPCa (i.e., any GG ≥ 3 lesion at target biopsy) by mpMRI radiomic features and analyzing similarities between GG groups. One hundred and two patients with 117 PIRADS ≥ 3 lesions at mpMRI underwent target+systematic biopsy, providing histologic diagnosis of PCa, 61 GG < 3 and 56 GG ≥ 3. Features were generated locally from an apparent diffusion coefficient and selected, using the LASSO method and Wilcoxon rank-sum test (p < 0.001), to achieve only four features. After data augmentation, the features were exploited to train a support vector machine classifier, subsequently validated on a test set. To assess the results, Kruskal–Wallis and Wilcoxon rank-sum tests (p < 0.001) and receiver operating characteristic (ROC)-related metrics were used. GG1 and GG2 were equivalent (p = 0.26), whilst clear separations between either GG[1,2] and GG ≥ 3 exist (p < 10 [Formula: see text]). On the test set, the area under the curve = 0.88 (95% CI, 0.68–0.94), with positive and negative predictive values being 84%. The features retain a histological interpretation. Our model hints at GG2 being much more similar to GG1 than GG ≥ 3. MDPI 2022-12-14 /pmc/articles/PMC9776977/ /pubmed/36551642 http://dx.doi.org/10.3390/cancers14246156 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gaudiano, Caterina
Mottola, Margherita
Bianchi, Lorenzo
Corcioni, Beniamino
Cattabriga, Arrigo
Cocozza, Maria Adriana
Palmeri, Antonino
Coppola, Francesca
Giunchi, Francesca
Schiavina, Riccardo
Fiorentino, Michelangelo
Brunocilla, Eugenio
Golfieri, Rita
Bevilacqua, Alessandro
Beyond Multiparametric MRI and towards Radiomics to Detect Prostate Cancer: A Machine Learning Model to Predict Clinically Significant Lesions
title Beyond Multiparametric MRI and towards Radiomics to Detect Prostate Cancer: A Machine Learning Model to Predict Clinically Significant Lesions
title_full Beyond Multiparametric MRI and towards Radiomics to Detect Prostate Cancer: A Machine Learning Model to Predict Clinically Significant Lesions
title_fullStr Beyond Multiparametric MRI and towards Radiomics to Detect Prostate Cancer: A Machine Learning Model to Predict Clinically Significant Lesions
title_full_unstemmed Beyond Multiparametric MRI and towards Radiomics to Detect Prostate Cancer: A Machine Learning Model to Predict Clinically Significant Lesions
title_short Beyond Multiparametric MRI and towards Radiomics to Detect Prostate Cancer: A Machine Learning Model to Predict Clinically Significant Lesions
title_sort beyond multiparametric mri and towards radiomics to detect prostate cancer: a machine learning model to predict clinically significant lesions
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776977/
https://www.ncbi.nlm.nih.gov/pubmed/36551642
http://dx.doi.org/10.3390/cancers14246156
work_keys_str_mv AT gaudianocaterina beyondmultiparametricmriandtowardsradiomicstodetectprostatecanceramachinelearningmodeltopredictclinicallysignificantlesions
AT mottolamargherita beyondmultiparametricmriandtowardsradiomicstodetectprostatecanceramachinelearningmodeltopredictclinicallysignificantlesions
AT bianchilorenzo beyondmultiparametricmriandtowardsradiomicstodetectprostatecanceramachinelearningmodeltopredictclinicallysignificantlesions
AT corcionibeniamino beyondmultiparametricmriandtowardsradiomicstodetectprostatecanceramachinelearningmodeltopredictclinicallysignificantlesions
AT cattabrigaarrigo beyondmultiparametricmriandtowardsradiomicstodetectprostatecanceramachinelearningmodeltopredictclinicallysignificantlesions
AT cocozzamariaadriana beyondmultiparametricmriandtowardsradiomicstodetectprostatecanceramachinelearningmodeltopredictclinicallysignificantlesions
AT palmeriantonino beyondmultiparametricmriandtowardsradiomicstodetectprostatecanceramachinelearningmodeltopredictclinicallysignificantlesions
AT coppolafrancesca beyondmultiparametricmriandtowardsradiomicstodetectprostatecanceramachinelearningmodeltopredictclinicallysignificantlesions
AT giunchifrancesca beyondmultiparametricmriandtowardsradiomicstodetectprostatecanceramachinelearningmodeltopredictclinicallysignificantlesions
AT schiavinariccardo beyondmultiparametricmriandtowardsradiomicstodetectprostatecanceramachinelearningmodeltopredictclinicallysignificantlesions
AT fiorentinomichelangelo beyondmultiparametricmriandtowardsradiomicstodetectprostatecanceramachinelearningmodeltopredictclinicallysignificantlesions
AT brunocillaeugenio beyondmultiparametricmriandtowardsradiomicstodetectprostatecanceramachinelearningmodeltopredictclinicallysignificantlesions
AT golfieririta beyondmultiparametricmriandtowardsradiomicstodetectprostatecanceramachinelearningmodeltopredictclinicallysignificantlesions
AT bevilacquaalessandro beyondmultiparametricmriandtowardsradiomicstodetectprostatecanceramachinelearningmodeltopredictclinicallysignificantlesions